(WEN) The Wendy’s - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US95058W1009
Stock:
Total Rating 32
Risk 66
Buy Signal 0.05
| Risk 5d forecast | |
|---|---|
| Volatility | 57.4% |
| Relative Tail Risk | -6.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.52 |
| Alpha | -57.73 |
| Character TTM | |
|---|---|
| Beta | 0.395 |
| Beta Downside | 0.605 |
| Drawdowns 3y | |
|---|---|
| Max DD | 65.76% |
| CAGR/Max DD | -0.40 |
EPS (Earnings per Share)
Revenue
Description: WEN The Wendy’s
The Wendy's Company, together with its subsidiaries, operates as a quick-service restaurant company in the United States and internationally. It operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development segments. The company involved in operating, developing, and franchising a system of quick-service restaurants specializing in hamburger sandwiches. It also owns and leases real estate properties. The company was formerly known as Wendy's/Arby's Group, Inc. and changed its name to The Wendy's Company in July 2011. The Wendy's Company was founded in 1969 and is headquartered in Dublin, Ohio.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 165.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.29 > 1.0 |
| NWC/Revenue: 12.26% < 20% (prev 15.07%; Δ -2.81% < -1%) |
| CFO/TA 0.07 > 3% & CFO 344.5m > Net Income 165.1m |
| Net Debt (3.84b) to EBITDA (424.8m): 9.05 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (190.5m) vs 12m ago -7.07% < -2% |
| Gross Margin: 27.17% > 18% (prev 0.35%; Δ 2681 % > 0.5%) |
| Asset Turnover: 43.58% > 50% (prev 44.62%; Δ -1.04% > 0%) |
| Interest Coverage Ratio: 2.04 > 6 (EBITDA TTM 424.8m / Interest Expense TTM 126.5m) |
Altman Z'' 1.08
| A: 0.05 (Total Current Assets 618.0m - Total Current Liabilities 351.1m) / Total Assets 4.96b |
| B: 0.09 (Retained Earnings 435.1m / Total Assets 4.96b) |
| C: 0.05 (EBIT TTM 258.1m / Avg Total Assets 5.00b) |
| D: 0.09 (Book Value of Equity 418.2m / Total Liabilities 4.84b) |
| Altman-Z'' Score: 1.08 = BB |
Beneish M -2.40
| DSRI: 1.21 (Receivables 117.3m/99.9m, Revenue 2.18b/2.25b) |
| GMI: 1.31 (GM 27.17% / 35.48%) |
| AQI: 1.39 (AQ_t 0.68 / AQ_t-1 0.49) |
| SGI: 0.97 (Revenue 2.18b / 2.25b) |
| TATA: -0.04 (NI 165.1m - CFO 344.5m) / TA 4.96b) |
| Beneish M-Score: -2.40 (Cap -4..+1) = BBB |
What is the price of WEN shares?
As of February 27, 2026, the stock is trading at USD 7.74 with a total of 7,035,297 shares traded.
Over the past week, the price has changed by -6.97%, over one month by -4.21%, over three months by -7.73% and over the past year by -47.03%.
Over the past week, the price has changed by -6.97%, over one month by -4.21%, over three months by -7.73% and over the past year by -47.03%.
Is WEN a buy, sell or hold?
The Wendy’s has received a consensus analysts rating of 3.28.
Therefor, it is recommend to hold WEN.
- StrongBuy: 5
- Buy: 2
- Hold: 19
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the WEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.2 | 6.5% |
| Analysts Target Price | 8.2 | 6.5% |
WEN Fundamental Data Overview February 24, 2026
P/E Trailing = 9.5176
P/E Forward = 9.6525
P/S = 0.7073
P/B = 15.8849
P/EG = 1.0159
Revenue TTM = 2.18b USD
EBIT TTM = 258.1m USD
EBITDA TTM = 424.8m USD
Long Term Debt = 2.30b USD (from longTermDebt, two quarters ago)
Short Term Debt = 107.5m USD (from shortTermDebt, last quarter)
Debt = 4.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b USD (from netDebt column, last quarter)
Enterprise Value = 5.38b USD (1.54b + Debt 4.15b - CCE 300.8m)
Interest Coverage Ratio = 2.04 (Ebit TTM 258.1m / Interest Expense TTM 126.5m)
EV/FCF = 22.19x (Enterprise Value 5.38b / FCF TTM 242.6m)
FCF Yield = 4.51% (FCF TTM 242.6m / Enterprise Value 5.38b)
FCF Margin = 11.15% (FCF TTM 242.6m / Revenue TTM 2.18b)
Net Margin = 7.58% (Net Income TTM 165.1m / Revenue TTM 2.18b)
Gross Margin = 27.17% ((Revenue TTM 2.18b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 24.21% (prev 26.48%)
Tobins Q-Ratio = 1.09 (Enterprise Value 5.38b / Total Assets 4.96b)
Interest Expense / Debt = 0.78% (Interest Expense 32.5m / Debt 4.15b)
Taxrate = 20.22% (6.71m / 33.2m)
NOPAT = 205.9m (EBIT 258.1m * (1 - 20.22%))
Current Ratio = 1.76 (Total Current Assets 618.0m / Total Current Liabilities 351.1m)
Debt / Equity = 35.31 (Debt 4.15b / totalStockholderEquity, last quarter 117.4m)
Debt / EBITDA = 9.05 (Net Debt 3.84b / EBITDA 424.8m)
Debt / FCF = 15.84 (Net Debt 3.84b / FCF TTM 242.6m)
Total Stockholder Equity = 117.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.30% (Net Income 165.1m / Total Assets 4.96b)
RoE = 140.6% (Net Income TTM 165.1m / Total Stockholder Equity 117.4m)
RoCE = 10.68% (EBIT 258.1m / Capital Employed (Equity 117.4m + L.T.Debt 2.30b))
RoIC = 7.23% (NOPAT 205.9m / Invested Capital 2.85b)
WACC = 2.45% (E(1.54b)/V(5.68b) * Re(7.35%) + D(4.15b)/V(5.68b) * Rd(0.78%) * (1-Tc(0.20)))
Discount Rate = 7.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.19%
[DCF] Terminal Value 86.85% ; FCFF base≈249.9m ; Y1≈263.5m ; Y5≈310.2m
[DCF] Fair Price = 28.14 (EV 9.20b - Net Debt 3.84b = Equity 5.36b / Shares 190.3m; r=5.90% [WACC]; 5y FCF grow 5.96% → 2.90% )
EPS Correlation: 4.41 | EPS CAGR: -1.60% | SUE: 0.45 | # QB: 0
Revenue Correlation: 51.35 | Revenue CAGR: 2.85% | SUE: 0.87 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.10 | Chg7d=-0.075 | Chg30d=-0.079 | Revisions Net=-19 | Analysts=23
EPS current Year (2026-12-31): EPS=0.58 | Chg7d=-0.269 | Chg30d=-0.290 | Revisions Net=-16 | Growth EPS=-33.5% | Growth Revenue=+1.4%
EPS next Year (2027-12-31): EPS=0.68 | Chg7d=-0.210 | Chg30d=-0.238 | Revisions Net=-13 | Growth EPS=+17.0% | Growth Revenue=+1.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 19 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.6% (Discount Rate 7.9% - Earnings Yield 10.5%)
[Growth] Growth Spread = +2.5% (Analyst -0.1% - Implied -2.6%)
P/E Forward = 9.6525
P/S = 0.7073
P/B = 15.8849
P/EG = 1.0159
Revenue TTM = 2.18b USD
EBIT TTM = 258.1m USD
EBITDA TTM = 424.8m USD
Long Term Debt = 2.30b USD (from longTermDebt, two quarters ago)
Short Term Debt = 107.5m USD (from shortTermDebt, last quarter)
Debt = 4.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b USD (from netDebt column, last quarter)
Enterprise Value = 5.38b USD (1.54b + Debt 4.15b - CCE 300.8m)
Interest Coverage Ratio = 2.04 (Ebit TTM 258.1m / Interest Expense TTM 126.5m)
EV/FCF = 22.19x (Enterprise Value 5.38b / FCF TTM 242.6m)
FCF Yield = 4.51% (FCF TTM 242.6m / Enterprise Value 5.38b)
FCF Margin = 11.15% (FCF TTM 242.6m / Revenue TTM 2.18b)
Net Margin = 7.58% (Net Income TTM 165.1m / Revenue TTM 2.18b)
Gross Margin = 27.17% ((Revenue TTM 2.18b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 24.21% (prev 26.48%)
Tobins Q-Ratio = 1.09 (Enterprise Value 5.38b / Total Assets 4.96b)
Interest Expense / Debt = 0.78% (Interest Expense 32.5m / Debt 4.15b)
Taxrate = 20.22% (6.71m / 33.2m)
NOPAT = 205.9m (EBIT 258.1m * (1 - 20.22%))
Current Ratio = 1.76 (Total Current Assets 618.0m / Total Current Liabilities 351.1m)
Debt / Equity = 35.31 (Debt 4.15b / totalStockholderEquity, last quarter 117.4m)
Debt / EBITDA = 9.05 (Net Debt 3.84b / EBITDA 424.8m)
Debt / FCF = 15.84 (Net Debt 3.84b / FCF TTM 242.6m)
Total Stockholder Equity = 117.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.30% (Net Income 165.1m / Total Assets 4.96b)
RoE = 140.6% (Net Income TTM 165.1m / Total Stockholder Equity 117.4m)
RoCE = 10.68% (EBIT 258.1m / Capital Employed (Equity 117.4m + L.T.Debt 2.30b))
RoIC = 7.23% (NOPAT 205.9m / Invested Capital 2.85b)
WACC = 2.45% (E(1.54b)/V(5.68b) * Re(7.35%) + D(4.15b)/V(5.68b) * Rd(0.78%) * (1-Tc(0.20)))
Discount Rate = 7.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.19%
[DCF] Terminal Value 86.85% ; FCFF base≈249.9m ; Y1≈263.5m ; Y5≈310.2m
[DCF] Fair Price = 28.14 (EV 9.20b - Net Debt 3.84b = Equity 5.36b / Shares 190.3m; r=5.90% [WACC]; 5y FCF grow 5.96% → 2.90% )
EPS Correlation: 4.41 | EPS CAGR: -1.60% | SUE: 0.45 | # QB: 0
Revenue Correlation: 51.35 | Revenue CAGR: 2.85% | SUE: 0.87 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.10 | Chg7d=-0.075 | Chg30d=-0.079 | Revisions Net=-19 | Analysts=23
EPS current Year (2026-12-31): EPS=0.58 | Chg7d=-0.269 | Chg30d=-0.290 | Revisions Net=-16 | Growth EPS=-33.5% | Growth Revenue=+1.4%
EPS next Year (2027-12-31): EPS=0.68 | Chg7d=-0.210 | Chg30d=-0.238 | Revisions Net=-13 | Growth EPS=+17.0% | Growth Revenue=+1.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 19 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.6% (Discount Rate 7.9% - Earnings Yield 10.5%)
[Growth] Growth Spread = +2.5% (Analyst -0.1% - Implied -2.6%)